Skip to main content
PMC home page
Annals of The Royal College of Surgeons of England logoLink to Annals of The Royal College of Surgeons of England
. 1996 Jul;78(4):354–358.

Parathyroid hormone-related protein, bone metastases and hypercalcaemia of malignancy.

N J Bundred 1, J Walls 1, W A Ratcliffe 1
PMCID: PMC2502594  PMID: 8712650

Abstract

Breast cancer patients frequently develop bone metastases. A newly discovered peptide, Parathyroid Hormone Related Protein (PTHrP), causes humoral hypercalcaemia of malignancy. We have studied whether production of this protein by breast cancers leads to the development of bone metastases or hypercalcaemia. PTHrP was produced by nearly 60% of early breast cancers and its production by the tumours was associated with malignant mammographic microcalcification, and the development of both bone metastases and hypercalcaemia. The hypercalcaemia associated with bone metastases has been shown to have a significant humoral component and measurement of plasma PTHrP in patients with hypercalcaemia is diagnostically useful. Potential mechanisms of preventing bone metastasis are discussed.

Full text

PDF
354

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arguello F., Baggs R. B., Frantz C. N. A murine model of experimental metastasis to bone and bone marrow. Cancer Res. 1988 Dec 1;48(23):6876–6881. [PubMed] [Google Scholar]
  2. Bundred N. J., Ratcliffe W. A., Walker R. A., Coley S., Morrison J. M., Ratcliffe J. G. Parathyroid hormone related protein and hypercalcaemia in breast cancer. BMJ. 1991 Dec 14;303(6816):1506–1509. doi: 10.1136/bmj.303.6816.1506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bundred N. J., Walker R. A., Ratcliffe W. A., Warwick J., Morrison J. M., Ratcliffe J. G. Parathyroid hormone related protein and skeletal morbidity in breast cancer. Eur J Cancer. 1992;28(2-3):690–692. doi: 10.1016/s0959-8049(05)80127-3. [DOI] [PubMed] [Google Scholar]
  4. Coleman R. E., Rubens R. D. The clinical course of bone metastases from breast cancer. Br J Cancer. 1987 Jan;55(1):61–66. doi: 10.1038/bjc.1987.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gallacher S. J., Fraser W. D., Patel U., Logue F. C., Soukop M., Boyle I. T., Ralston S. H. Breast cancer-associated hypercalcaemia: a reassessment of renal calcium and phosphate handling. Ann Clin Biochem. 1990 Nov;27(Pt 6):551–556. doi: 10.1177/000456329002700605. [DOI] [PubMed] [Google Scholar]
  6. Hirschhorn R., Paageorgiou P. S., Kesarwala H. H., Taft L. T. Amerioration of neurologic abnormalities after "enzyme replacement" in adenosine deaminase deficiency. N Engl J Med. 1980 Aug 14;303(7):377–380. doi: 10.1056/NEJM198008143030706. [DOI] [PubMed] [Google Scholar]
  7. Iwamura M., di Sant'Agnese P. A., Wu G., Benning C. M., Cockett A. T., Deftos L. J., Abrahamsson P. A. Immunohistochemical localization of parathyroid hormone-related protein in human prostate cancer. Cancer Res. 1993 Apr 15;53(8):1724–1726. [PubMed] [Google Scholar]
  8. Martin T. J., Suva L. J. Parathyroid hormone-related protein in hypercalcaemia of malignancy. Clin Endocrinol (Oxf) 1989 Nov;31(5):631–647. doi: 10.1111/j.1365-2265.1989.tb01288.x. [DOI] [PubMed] [Google Scholar]
  9. Mundy G. R., Martin T. J. The hypercalcemia of malignancy: pathogenesis and management. Metabolism. 1982 Dec;31(12):1247–1277. doi: 10.1016/0026-0495(82)90012-9. [DOI] [PubMed] [Google Scholar]
  10. Percival R. C., Yates A. J., Gray R. E., Galloway J., Rogers K., Neal F. E., Kanis J. A. Mechanism of malignant hypercalcaemia in carcinoma of the breast. Br Med J (Clin Res Ed) 1985 Sep 21;291(6498):776–779. doi: 10.1136/bmj.291.6498.776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Powell G. J., Southby J., Danks J. A., Stillwell R. G., Hayman J. A., Henderson M. A., Bennett R. C., Martin T. J. Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res. 1991 Jun 1;51(11):3059–3061. [PubMed] [Google Scholar]
  12. Sano M., Kushida K., Takahashi M., Ohishi T., Kawana K., Okada M., Inoue T. Urinary pyridinoline and deoxypyridinoline in prostate carcinoma patients with bone metastasis. Br J Cancer. 1994 Oct;70(4):701–703. doi: 10.1038/bjc.1994.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Walls J., Ratcliffe W. A., Howell A., Bundred N. J. Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcaemia in two hospital populations. Clin Endocrinol (Oxf) 1994 Oct;41(4):407–413. doi: 10.1111/j.1365-2265.1994.tb02569.x. [DOI] [PubMed] [Google Scholar]
  14. Yoneda T., Sasaki A., Mundy G. R. Osteolytic bone metastasis in breast cancer. Breast Cancer Res Treat. 1994;32(1):73–84. doi: 10.1007/BF00666208. [DOI] [PubMed] [Google Scholar]

Articles from Annals of The Royal College of Surgeons of England are provided here courtesy of The Royal College of Surgeons of England

RESOURCES